赛诺生物获数千万元Pre-A轮融资，推进非粮生物质酶制剂国产替代进程

Core Viewpoint - The article discusses the recent Pre-A financing of Baiyin Saino Biotechnology Co., Ltd. (Saino Bio), highlighting its advancements in enzyme technology for non-grain biomass processing and its strategic positioning in the market [2][4]. Group 1: Financing and Investment - Saino Bio completed a Pre-A round financing of several tens of millions, led by Guotou Juliy and followed by Shen Dan Venture Capital, with Kai Cheng Capital serving as the exclusive financial advisor [2]. - The funds will be used for the production capacity construction of core products such as enzymes for non-grain biomass refining and special enzymes for grain deep processing, as well as the iteration of the EnzymeSyn-Cycle AI+ technology platform [2]. Group 2: Market Potential and Technology - The non-grain biomass manufacturing industry is crucial for China's "dual carbon" goals, with expectations that by 2030, non-grain-based products will replace over 30% of grain-based products, leading to explosive market growth [4]. - Saino Bio has achieved a breakthrough in enzyme technology for non-grain biomass refining, significantly improving enzyme efficiency and reducing costs, positioning itself at an international leading level [4]. Group 3: Competitive Advantage and Product Development - The EnzymeSyn-Cycle AI+ technology platform integrates advanced technologies for protein rational design, enhancing the adaptability of enzyme molecules to industrial environments, thus supporting continuous innovation and domestic substitution of high-end industrial enzymes [6]. - Saino Bio has established a leading market position in various enzyme applications, including grain deep processing and food processing, with its fiber washing enzyme for corn starch production being a global first and the best-performing enzyme in the domestic market [6]. Group 4: Future Outlook and Strategic Importance - The chairman of Saino Bio emphasized the importance of this financing as a milestone for the company's development, with plans to increase investment in technology R&D and production capacity to accelerate the industrialization of high-value utilization of non-grain biomass [7]. - Investors recognize the strategic value and vast market potential of efficient non-grain biomass utilization, with Saino Bio being one of the few companies mastering core enzyme technology in this field, making it a rare investment target for long-term positioning in the non-grain bio-manufacturing sector [8].